Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Navigating Two Roads to Glucose Normalization in Diabetes: Automated Insulin Delivery Devices and Cell Therapy.

Latres E, Finan DA, Greenstein JL, Kowalski A, Kieffer TJ.

Cell Metab. 2019 Mar 5;29(3):545-563. doi: 10.1016/j.cmet.2019.02.007. Review.

PMID:
30840911
2.

Defining Outcomes for β-cell Replacement Therapy in the Treatment of Diabetes: A Consensus Report on the Igls Criteria From the IPITA/EPITA Opinion Leaders Workshop.

Rickels MR, Stock PG, de Koning EJP, Piemonti L, Pratschke J, Alejandro R, Bellin MD, Berney T, Choudhary P, Johnson PR, Kandaswamy R, Kay TWH, Keymeulen B, Kudva YC, Latres E, Langer RM, Lehmann R, Ludwig B, Markmann JF, Marinac M, Odorico JS, Pattou F, Senior PA, Shaw JAM, Vantyghem MC, White S.

Transplantation. 2018 Sep;102(9):1479-1486. doi: 10.1097/TP.0000000000002158. Review.

3.

Defining outcomes for β-cell replacement therapy in the treatment of diabetes: a consensus report on the Igls criteria from the IPITA/EPITA opinion leaders workshop.

Rickels MR, Stock PG, de Koning EJP, Piemonti L, Pratschke J, Alejandro R, Bellin MD, Berney T, Choudhary P, Johnson PR, Kandaswamy R, Kay TWH, Keymeulen B, Kudva YC, Latres E, Langer RM, Lehmann R, Ludwig B, Markmann JF, Marinac M, Odorico JS, Pattou F, Senior PA, Shaw JAM, Vantyghem MC, White S.

Transpl Int. 2018 Apr;31(4):343-352. doi: 10.1111/tri.13138. Review.

4.

Activin A more prominently regulates muscle mass in primates than does GDF8.

Latres E, Mastaitis J, Fury W, Miloscio L, Trejos J, Pangilinan J, Okamoto H, Cavino K, Na E, Papatheodorou A, Willer T, Bai Y, Hae Kim J, Rafique A, Jaspers S, Stitt T, Murphy AJ, Yancopoulos GD, Gromada J.

Nat Commun. 2017 Apr 28;8:15153. doi: 10.1038/ncomms15153.

5.

Myostatin deficiency but not anti-myostatin blockade induces marked proteomic changes in mouse skeletal muscle.

Salzler RR, Shah D, Doré A, Bauerlein R, Miloscio L, Latres E, Papadopoulos NJ, Olson WC, MacDonald D, Duan X.

Proteomics. 2016 Jul;16(14):2019-27. doi: 10.1002/pmic.201600006.

PMID:
27214824
6.

Myostatin blockade with a fully human monoclonal antibody induces muscle hypertrophy and reverses muscle atrophy in young and aged mice.

Latres E, Pangilinan J, Miloscio L, Bauerlein R, Na E, Potocky TB, Huang Y, Eckersdorff M, Rafique A, Mastaitis J, Lin C, Murphy AJ, Yancopoulos GD, Gromada J, Stitt T.

Skelet Muscle. 2015 Oct 9;5:34. doi: 10.1186/s13395-015-0060-8. eCollection 2015.

7.

Conditionals by inversion provide a universal method for the generation of conditional alleles.

Economides AN, Frendewey D, Yang P, Dominguez MG, Dore AT, Lobov IB, Persaud T, Rojas J, McClain J, Lengyel P, Droguett G, Chernomorsky R, Stevens S, Auerbach W, Dechiara TM, Pouyemirou W, Cruz JM Jr, Feeley K, Mellis IA, Yasenchack J, Hatsell SJ, Xie L, Latres E, Huang L, Zhang Y, Pefanis E, Skokos D, Deckelbaum RA, Croll SD, Davis S, Valenzuela DM, Gale NW, Murphy AJ, Yancopoulos GD.

Proc Natl Acad Sci U S A. 2013 Aug 20;110(34):E3179-88. doi: 10.1073/pnas.1217812110. Epub 2013 Aug 5.

8.

During muscle atrophy, thick, but not thin, filament components are degraded by MuRF1-dependent ubiquitylation.

Cohen S, Brault JJ, Gygi SP, Glass DJ, Valenzuela DM, Gartner C, Latres E, Goldberg AL.

J Cell Biol. 2009 Jun 15;185(6):1083-95. doi: 10.1083/jcb.200901052. Epub 2009 Jun 8.

9.

The CAMplexities of central ghrelin.

Sleeman MW, Latres E.

Cell Metab. 2008 May;7(5):361-2. doi: 10.1016/j.cmet.2008.04.009.

10.

The E3 Ligase MuRF1 degrades myosin heavy chain protein in dexamethasone-treated skeletal muscle.

Clarke BA, Drujan D, Willis MS, Murphy LO, Corpina RA, Burova E, Rakhilin SV, Stitt TN, Patterson C, Latres E, Glass DJ.

Cell Metab. 2007 Nov;6(5):376-85.

11.

Genetic deletion of Trb3, the mammalian Drosophila tribbles homolog, displays normal hepatic insulin signaling and glucose homeostasis.

Okamoto H, Latres E, Liu R, Thabet K, Murphy A, Valenzeula D, Yancopoulos GD, Stitt TN, Glass DJ, Sleeman MW.

Diabetes. 2007 May;56(5):1350-6. Epub 2007 Feb 15.

12.

Insulin-like growth factor-1 (IGF-1) inversely regulates atrophy-induced genes via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway.

Latres E, Amini AR, Amini AA, Griffiths J, Martin FJ, Wei Y, Lin HC, Yancopoulos GD, Glass DJ.

J Biol Chem. 2005 Jan 28;280(4):2737-44. Epub 2004 Nov 17.

13.

Role of F-box protein betaTrcp1 in mammary gland development and tumorigenesis.

Kudo Y, Guardavaccaro D, Santamaria PG, Koyama-Nasu R, Latres E, Bronson R, Yamasaki L, Pagano M.

Mol Cell Biol. 2004 Sep;24(18):8184-94.

14.

Identification of ubiquitin ligases required for skeletal muscle atrophy.

Bodine SC, Latres E, Baumhueter S, Lai VK, Nunez L, Clarke BA, Poueymirou WT, Panaro FJ, Na E, Dharmarajan K, Pan ZQ, Valenzuela DM, DeChiara TM, Stitt TN, Yancopoulos GD, Glass DJ.

Science. 2001 Nov 23;294(5547):1704-8. Epub 2001 Oct 25.

15.

The de-ubiquitinating enzyme Unp interacts with the retinoblastoma protein.

DeSalle LM, Latres E, Lin D, Graner E, Montagnoli A, Baker RT, Pagano M, Loda M.

Oncogene. 2001 Sep 6;20(39):5538-42.

16.

Induction of beta-transducin repeat-containing protein by JNK signaling and its role in the activation of NF-kappaB.

Spiegelman VS, Stavropoulos P, Latres E, Pagano M, Ronai Z, Slaga TJ, Fuchs SY.

J Biol Chem. 2001 Jul 20;276(29):27152-8. Epub 2001 May 24.

17.

Control of spermatogenesis in mice by the cyclin D-dependent kinase inhibitors p18(Ink4c) and p19(Ink4d).

Zindy F, den Besten W, Chen B, Rehg JE, Latres E, Barbacid M, Pollard JW, Sherr CJ, Cohen PE, Roussel MF.

Mol Cell Biol. 2001 May;21(9):3244-55.

18.

Role of the F-box protein Skp2 in lymphomagenesis.

Latres E, Chiarle R, Schulman BA, Pavletich NP, Pellicer A, Inghirami G, Pagano M.

Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2515-20. Epub 2001 Feb 20.

19.

Limited overlapping roles of P15(INK4b) and P18(INK4c) cell cycle inhibitors in proliferation and tumorigenesis.

Latres E, Malumbres M, Sotillo R, Martín J, Ortega S, Martín-Caballero J, Flores JM, Cordón-Cardo C, Barbacid M.

EMBO J. 2000 Jul 3;19(13):3496-506.

20.
21.

Cyclin-dependent kinase inhibitor p57KIP2 in soft tissue sarcomas and Wilms'tumors.

Orlow I, Iavarone A, Crider-Miller SJ, Bonilla F, Latres E, Lee MH, Gerald WL, Massagué J, Weissman BE, Cordón-Cardó C.

Cancer Res. 1996 Mar 15;56(6):1219-21.

22.

Altered patterns of retinoblastoma gene product expression in adult soft-tissue sarcomas.

Karpeh MS, Brennan MF, Cance WG, Woodruff JM, Pollack D, Casper ES, Dudas ME, Latres E, Drobnjak M, Cordon-Cardo C.

Br J Cancer. 1995 Oct;72(4):986-91.

23.

Genetic evidence in melanoma and bladder cancers that p16 and p53 function in separate pathways of tumor suppression.

Gruis NA, Weaver-Feldhaus J, Liu Q, Frye C, Eeles R, Orlow I, Lacombe L, Ponce-Castaneda V, Lianes P, Latres E, et al.

Am J Pathol. 1995 May;146(5):1199-206.

24.

p27Kip1: chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors.

Ponce-Castañeda MV, Lee MH, Latres E, Polyak K, Lacombe L, Montgomery K, Mathew S, Krauter K, Sheinfeld J, Massague J, et al.

Cancer Res. 1995 Mar 15;55(6):1211-4.

25.

A new polymorphic site in intron 2 of TP53 characterizes LOH in human tumors by PCR-SSCP.

Oliva MR, Saez GT, Latres E, Cordon-Cardo C.

Diagn Mol Pathol. 1995 Mar;4(1):54-8.

PMID:
7735557
26.

Chromosome 17 abnormalities and TP53 mutations in adult soft tissue sarcomas.

Latres E, Drobnjak M, Pollack D, Oliva MR, Ramos M, Karpeh M, Woodruff JM, Cordon-Cardo C.

Am J Pathol. 1994 Aug;145(2):345-55.

27.

Prognostic implications of p53 nuclear overexpression and high proliferation index of Ki-67 in adult soft-tissue sarcomas.

Drobnjak M, Latres E, Pollack D, Karpeh M, Dudas M, Woodruff JM, Brennan MF, Cordon-Cardo C.

J Natl Cancer Inst. 1994 Apr 6;86(7):549-54.

PMID:
8133539
28.

Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas.

Cordon-Cardo C, Latres E, Drobnjak M, Oliva MR, Pollack D, Woodruff JM, Marechal V, Chen J, Brennan MF, Levine AJ.

Cancer Res. 1994 Feb 1;54(3):794-9.

29.

A radio-enzymatic method for the estimation of L-leucine-specific radioactivity.

Fernández-López JA, Latres E, Remesar X, Alemany M.

J Biochem Biophys Methods. 1993 Jul;26(4):291-7.

PMID:
8409201
30.

Short-term oscillations of aortic core temperature and thermogenic organ blood flow in the rat.

Closa D, Gómez-Sierra JM, Latres E, Alemany M, Remesar X.

Exp Physiol. 1993 Mar;78(2):243-53.

31.

Measurement of rat lung blood flow with labelled microspheres.

Latres E, Closa D, Gómez-Sierra JM, Alemany M, Remesae X.

Arch Int Physiol Biochim Biophys. 1992 May-Jun;100(3):263-5.

PMID:
1382677
32.

An enzymatic method for the estimation of L-leucine in rat blood.

Latres E, Fernández-López JA, Remesar X, Alemany M.

J Biochem Biophys Methods. 1992 Mar;24(1-2):39-44.

PMID:
1560179

Supplemental Content

Loading ...
Support Center